Showing results (1-10 of 158) with videos related to
Sort By:
Pageof 16
Archiv Der Pharmazie|May 13, 2015
Synthesis of novel triplets with a 1,3,5-trioxazatriquinane skeleton and their pharmacologies for opioid receptorsHiroshi Nagase, Noriki KutsumuraCurrent Pharmaceutical Design|March 2, 2013
Essential structure of the κ opioid receptor agonist nalfurafine for binding to the κ receptorHiroshi Nagase, Hideaki FujiiHandbook of Experimental Pharmacology|October 28, 2016
Delta Opioid Receptor (DOR) Ligands and Pharmacology: Development of Indolo- and Quinolinomorphinan Derivatives Based on the Message-Address ConceptAkiyoshi Saitoh, Hiroshi NagaseTopics in Current Chemistry|June 2, 2011
Opioids in preclinical and clinical trialsHiroshi Nagase, Hideaki FujiiPharmacology & Therapeutics|October 27, 2019
Research and development of κ opioid receptor agonists and δ opioid receptor agonistsHiroshi Nagase, Akiyoshi SaitohTopics in Current Chemistry|June 2, 2011
Synthesis of novel basic skeletons derived from naltrexoneHiroshi Nagase, Hideaki FujiiExpert Opinion on Therapeutic Patents|May 28, 2013
Non-peptidic δ opioid receptor agonists and antagonists (2000 - 2012)Hideaki Fujii, Toshihiro Takahashi, Hiroshi NagaseOrganic Letters|January 27, 2006
Novel synthesis of the ortho ester derivative of 4,5-epoxymorphinanAkio Watanabe, Toshitsugu Kai, Hiroshi NagaseEuropean Journal of Pharmacology|April 23, 2003
The antitussive effects of endomorphin-1 and endomorphin-2 in miceJunzo Kamei, Kayo Morita, Akiyoshi Saitoh, et al.Neuroscience Letters|April 13, 2002
Modulation of kappa-opioidergic systems on mecamylamine-precipitated nicotine-withdrawal aversion in ratsYuya Ise, Minoru Narita, Hiroshi Nagase, et al.Pageof 16